Literature DB >> 8552301

Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion.

S J Pollack1, I I Sadler, S R Hawtin, V J Tailor, M S Shearman.   

Abstract

We recently reported that several sulfate-containing glycosaminoglycans, a class of compounds associated with the beta-amyloid plaques of Alzheimer's disease, attenuate the toxic effects of beta-amyloid fragments beta 25-35 and beta 1-40. The amyloid-binding sulfonated dye Congo Red was shown to have a similar effect. Using two clonal cell lines, we now demonstrate that several sulfonated dyes attenuate beta-amyloid toxicity and that the protective effect appears specific for compounds whose sulfonate groups can interact with the beta-pleated structure of aggregated amyloid. These results suggest that by binding beta-amyloid these compounds may prevent toxic interactions of the peptide with cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8552301     DOI: 10.1016/0304-3940(95)11939-t

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.

Authors:  D R Howlett; A E Perry; F Godfrey; J E Swatton; K H Jennings; C Spitzfaden; H Wadsworth; S J Wood; R E Markwell
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  An atomic model for the pleated beta-sheet structure of Abeta amyloid protofilaments.

Authors:  L Li; T A Darden; L Bartolotti; D Kominos; L G Pedersen
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

3.  Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice.

Authors:  A D Cohen; M D Ikonomovic; E E Abrahamson; W R Paljug; S T Dekosky; I M Lefterov; R P Koldamova; L Shao; M L Debnath; N S Mason; C A Mathis; W E Klunk
Journal:  Lett Drug Des Discov       Date:  2009-09       Impact factor: 1.150

4.  The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

Authors:  Richard W McLaughlin; Janelle K De Stigter; Laura A Sikkink; Elizabeth M Baden; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

5.  Atomic structures of corkscrew-forming segments of SOD1 reveal varied oligomer conformations.

Authors:  Smriti Sangwan; Michael R Sawaya; Kevin A Murray; Michael P Hughes; David S Eisenberg
Journal:  Protein Sci       Date:  2018-03-10       Impact factor: 6.725

6.  Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.

Authors:  M L Schmidt; V M Lee; M Forman; T S Chiu; J Q Trojanowski
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

7.  Structurally distinct toxicity inhibitors bind at common loci on β-amyloid fibril.

Authors:  Ben Keshet; Jeffrey J Gray; Theresa A Good
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

Review 8.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

Authors:  D Giulian; L J Haverkamp; J H Yu; W Karshin; D Tom; J Li; J Kirkpatrick; L M Kuo; A E Roher
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

10.  A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-β neurotoxicity by generating nontoxic aggregates.

Authors:  H Edward Wong; Wei Qi; Hyung-Min Choi; Erik J Fernandez; Inchan Kwon
Journal:  ACS Chem Neurosci       Date:  2011-09-06       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.